These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28421334)

  • 1. Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study.
    Herzog DP; Wagner S; Ruckes C; Tadic A; Roll SC; Härter M; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):711-721. PubMed ID: 28421334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
    Tadić A; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Röschke J; van Calker D; Wachtlin D; Kronfeld K; Gorbauch T; Seibert-Grafe M; Lieb K;
    Trials; 2010 Feb; 11():21. PubMed ID: 20187947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depression treatment in Germany-descriptive analysis of health insurance fund routine data and assessment of guideline-adherence.
    Wiegand HF; Sievers C; Schillinger M; Godemann F
    J Affect Disord; 2016 Jan; 189():246-53. PubMed ID: 26454184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
    Demyttenaere K; Adelin A; Patrick M; Walthère D; Katrien de B; Michèle S
    Int Clin Psychopharmacol; 2008 Jan; 23(1):36-42. PubMed ID: 18090506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.
    Preskorn S; Macaluso M; Mehra DO; Zammit G; Moskal JR; Burch RM;
    J Psychiatr Pract; 2015 Mar; 21(2):140-9. PubMed ID: 25782764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
    Schultz J; Joish V
    Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
    Tadić A; Wachtlin D; Berger M; Braus DF; van Calker D; Dahmen N; Dreimüller N; Engel A; Gorbulev S; Helmreich I; Kaiser AK; Kronfeld K; Schlicht KF; Tüscher O; Wagner S; Hiemke C; Lieb K
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):705-16. PubMed ID: 26899588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' support improves antidepressant adherence in the community.
    Klang SH; Ben-Amnon Y; Cohen Y; Barak Y
    Int Clin Psychopharmacol; 2015 Nov; 30(6):316-9. PubMed ID: 26163876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-consistent antidepressant treatment patterns among veterans with diabetes and major depressive disorder.
    Tiwari A; Rajan M; Miller D; Pogach L; Olfson M; Sambamoorthi U
    Psychiatr Serv; 2008 Oct; 59(10):1139-47. PubMed ID: 18832499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: a multi-center, naturalistic study.
    Han C; Wang SM; Seo HJ; Lee BC; Jeon HJ; Kim W; Kwak KP; Pae CU
    J Psychiatr Res; 2014 Feb; 49():75-82. PubMed ID: 24268719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression.
    Jordan N; Lee TA; Valenstein M; Weiss KB
    J Gen Intern Med; 2007 Oct; 22(10):1447-52. PubMed ID: 17687614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline-concordant antidepressant use among patients with major depressive disorder.
    Chen SY; Hansen RA; Gaynes BN; Farley JF; Morrissey JP; Maciejewski ML
    Gen Hosp Psychiatry; 2010; 32(4):360-7. PubMed ID: 20633739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-factor model of personality and antidepressant medication compliance.
    Cohen NL; Ross EC; Bagby RM; Farvolden P; Kennedy SH
    Can J Psychiatry; 2004 Feb; 49(2):106-13. PubMed ID: 15065744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Working with reactant patients: are we prescribing nonadherence?
    Madsen JW; McQuaid JR; Craighead WE
    Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.